Form 4 for TXG 10x Genomics, Inc.
Accepted 2021-11-03 00:00:00 ET · period of report 2021-11-01 · accession 0001567619-21-019297 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-03 | 2021-11-01 | TXG | Hindson Benjamin J. | See Remarks, Dir | S - Sale+OE | $163.58 | -41.7K | 74.4K | -36% | -$6.82M |
| DM | 2021-11-03 | 2021-11-01 | TXG | Hindson Benjamin J. | See Remarks, Dir | M - OptEx | $9.90 | +41.7K | 57.3K | +266% | +$412.4K |
| DM | 2021-11-03 | 2021-11-01 | TXG | Hindson Benjamin J. | See Remarks, Dir | M - OptEx | $0.00 | -41.7K | 68.6K | -38% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-11-01 | S | D | 1,100 | $160.50 | 87,683 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $160.00 to $160.95. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 2 | Common | Class A Common Stock | 2021-11-01 | S | D | 1,500 | $162.06 | 86,183 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $161.45 to $162.43. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Common | Class A Common Stock | 2021-11-01 | S | D | 24,125 | $163.87 | 50,229 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $163.48 to $164.47. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Common | Class A Common Stock | 2021-11-01 | S | D | 3,112 | $164.75 | 47,117 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $164.50 to $165.29. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 5 | Common | Class A Common Stock | 2021-11-01 | M | A | 31,434 | $11.48 | 88,783 | D | — | — | |
| 6 | Common | Class A Common Stock | 2021-11-01 | M | A | 10,232 | $5.04 | 57,349 | D | — | — | |
| 7 | Common | Class A Common Stock | 2021-11-01 | S | D | 11,829 | $163.15 | 74,354 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $162.48 to $163.475. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 8 | Derivative | Stock Option (right to buy) | 2021-11-01 | M | D | 10,232 | $0.00 | 50,884 | D | $5.04 · — to 2028-11-02 | 10,232 Class A Common Stock | (F7) This option, originally for 175,000 shares, of which 124,116 shares have been exercised, vested as to 1/48th of the shares on October 1, 2018 and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |
| 9 | Derivative | Stock Option (right to buy) | 2021-11-01 | M | D | 31,434 | $0.00 | 68,566 | D | $11.48 · — to 2029-05-10 | 31,434 Class A Common Stock | (F8) This option, originally for 100,000 shares, of which 31,434 shares have been exercised, vested as to 1/48th of the shares on May 1, 2019 and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |